Literature DB >> 33707576

MAGI1 inhibits the AMOTL2/p38 stress pathway and prevents luminal breast tumorigenesis.

Emilie Bousquet Mur1, Maicol Mancini1, Diala Kantar1, Vera Slaninova1, Yezza Ben Salah1, Luca Costa2, Elodie Forest1, Patrice Lassus1, Charles Géminard1, Florence Boissière-Michot1,3, Béatrice Orsetti1, Charles Theillet1, Jacques Colinge1, Christine Benistant2, Antonio Maraver1, Lisa Heron-Milhavet4, Alexandre Djiane5.   

Abstract

Alterations to cell polarization or to intercellular junctions are often associated with epithelial cancer progression, including breast cancers (BCa). We show here that the loss of the junctional scaffold protein MAGI1 is associated with bad prognosis in luminal BCa, and promotes tumorigenesis. E-cadherin and the actin binding scaffold AMOTL2 accumulate in MAGI1 deficient cells which are subjected to increased stiffness. These alterations are associated with low YAP activity, the terminal Hippo-pathway effector, but with an elevated ROCK and p38 Stress Activated Protein Kinase activities. Blocking ROCK prevented p38 activation, suggesting that MAGI1 limits p38 activity in part through releasing actin strength. Importantly, the increased tumorigenicity of MAGI1 deficient cells is rescued in the absence of AMOTL2 or after inhibition of p38, demonstrating that MAGI1 acts as a tumor-suppressor in luminal BCa by inhibiting an AMOTL2/p38 stress pathway.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33707576      PMCID: PMC7952706          DOI: 10.1038/s41598-021-85056-1

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  78 in total

Review 1.  The E-cadherin-catenin complex in tumour metastasis: structure, function and regulation.

Authors:  I R Beavon
Journal:  Eur J Cancer       Date:  2000-08       Impact factor: 9.162

Review 2.  Regulation and involvement in cancer and pathological conditions of MAGI1, a tight junction protein.

Authors:  Xuemin Feng; Shuqin Jia; Tracey A Martin; Wen G Jiang
Journal:  Anticancer Res       Date:  2014-07       Impact factor: 2.480

3.  E-cadherin mediates contact inhibition of proliferation through Hippo signaling-pathway components.

Authors:  Nam-Gyun Kim; Eunjin Koh; Xiao Chen; Barry M Gumbiner
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-05       Impact factor: 11.205

4.  Human T-cell leukemia virus type 1 Tax protein interacts with and mislocalizes the PDZ domain protein MAGI-1.

Authors:  Grace Naswa Makokha; Masahiko Takahashi; Masaya Higuchi; Suguru Saito; Yuetsu Tanaka; Masahiro Fujii
Journal:  Cancer Sci       Date:  2013-01-30       Impact factor: 6.716

5.  A central role for p38 MAPK in the early transcriptional response to stress.

Authors:  Alan J Whitmarsh
Journal:  BMC Biol       Date:  2010-04-27       Impact factor: 7.431

6.  TAZ is required for metastatic activity and chemoresistance of breast cancer stem cells.

Authors:  M Bartucci; R Dattilo; C Moriconi; A Pagliuca; M Mottolese; G Federici; A Di Benedetto; M Todaro; G Stassi; F Sperati; M I Amabile; E Pilozzi; M Patrizii; M Biffoni; M Maugeri-Saccà; S Piccolo; R De Maria
Journal:  Oncogene       Date:  2014-02-17       Impact factor: 9.867

7.  The nuclear translocation of the kinases p38 and JNK promotes inflammation-induced cancer.

Authors:  Galia Maik-Rachline; Elder Zehorai; Tamar Hanoch; John Blenis; Rony Seger
Journal:  Sci Signal       Date:  2018-04-10       Impact factor: 8.192

8.  E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells.

Authors:  U H Frixen; J Behrens; M Sachs; G Eberle; B Voss; A Warda; D Löchner; W Birchmeier
Journal:  J Cell Biol       Date:  1991-04       Impact factor: 10.539

Review 9.  Roles of p38α mitogen-activated protein kinase in mouse models of inflammatory diseases and cancer.

Authors:  Jalaj Gupta; Angel R Nebreda
Journal:  FEBS J       Date:  2015-03-16       Impact factor: 5.542

10.  AMOTL1 Promotes Breast Cancer Progression and Is Antagonized by Merlin.

Authors:  Christophe Couderc; Alizée Boin; Laetitia Fuhrmann; Anne Vincent-Salomon; Vinay Mandati; Yann Kieffer; Fatima Mechta-Grigoriou; Laurence Del Maestro; Philippe Chavrier; David Vallerand; Isabelle Brito; Thierry Dubois; Leanne De Koning; Daniel Bouvard; Daniel Louvard; Alexis Gautreau; Dominique Lallemand
Journal:  Neoplasia       Date:  2016-01       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.